IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Veraxa Biotech AG

CUSIP: H9130A103 | 8 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AAQR Capital Management LLC658,1380.5%Newly reportedJun 30, 2026Not yet in a 13F
13G/AAQR Capital Management LLC

Institutional Holders — Q3 2026

Geode Capital Management, LLC91,528
0.0% of portfolio›$114.4K
UBS Group AG72,142
0.0% of portfolio›$90.2K
Wolverine Asset Management LLC1,748
0.0% of portfolio›$2.2K
StyleTurnoverLocationFiled
Geode Capital Management, LLC
91,528$114.4K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
72,142$90.2K0.0%CoreMediumZurich, Switzerland2026-11-10
Wolverine Asset Management LLC
1,748$2.2K0.0%Deep ValueVery HighChicago, IL2026-11-02
658,138
0.5% of class · Jun 30, 2026Newly reported
Not yet in a 13F